DELPHARM

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	14-08-2025	14 d late	2025-00377015
31-12-2023	31-07-2024	07-06-2024	54 d early	2024-00116529
31-12-2022	31-07-2023	24-05-2023	68 d early	2023-00094663

Metric	This company	Sector median	Position in the sector
Solvency	24.7%	39.7%	better than 38% of 972 sector peers
Net result	€34k	€32k	better than 51% of 972 sector peers
Equity	€317k	€152k	better than 61% of 973 sector peers
Gross operating margin	€82k	€59k	better than 58% of 813 sector peers
Total assets	€1.28M	€748k	better than 59% of 972 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.28M
Fixed assets	21/28	€1.26M
Tangible fixed assets	22/27	€86k
Financial fixed assets	28	€1.17M
Current assets	29/58	€22k
Amounts receivable within one year	40/41	€2k
Cash & bank	54/58	€10k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.28M
Equity	10/15	€317k
Contributions / capital	10/11	€20k
Accumulated profits (losses)	14	€297k
Amounts payable	17/49	€965k
Amounts payable after one year	17	€794k
Amounts payable within one year	42/48	€163k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€82k
Operating result	9901	€65k
Financial charges	65	€22k
Result before taxes	9903	€43k
Income taxes	67/77	€9k
Net result for the period	9904	€34k
Result to be appropriated	9905	€34k

Summary